JP2022530533A5 - - Google Patents
Info
- Publication number
- JP2022530533A5 JP2022530533A5 JP2021564454A JP2021564454A JP2022530533A5 JP 2022530533 A5 JP2022530533 A5 JP 2022530533A5 JP 2021564454 A JP2021564454 A JP 2021564454A JP 2021564454 A JP2021564454 A JP 2021564454A JP 2022530533 A5 JP2022530533 A5 JP 2022530533A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- combination
- asthma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025080870A JP2025122028A (ja) | 2019-05-01 | 2025-05-14 | Ｉｌ－３３アンタゴニストを投与することにより喘息を治療するまたは予防するための方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962841481P | 2019-05-01 | 2019-05-01 | |
| US62/841,481 | 2019-05-01 | ||
| US201962848248P | 2019-05-15 | 2019-05-15 | |
| US62/848,248 | 2019-05-15 | ||
| US201962898900P | 2019-09-11 | 2019-09-11 | |
| US62/898,900 | 2019-09-11 | ||
| PCT/US2020/030824 WO2020223541A1 (en) | 2019-05-01 | 2020-04-30 | Methods for treating or preventing asthma by administering an il-33 antagonist |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025080870A Division JP2025122028A (ja) | 2019-05-01 | 2025-05-14 | Ｉｌ－３３アンタゴニストを投与することにより喘息を治療するまたは予防するための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022530533A JP2022530533A (ja) | 2022-06-29 |
| JP2022530533A5 true JP2022530533A5 (enExample) | 2024-09-13 |
Family
ID=70802932
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564454A Pending JP2022530533A (ja) | 2019-05-01 | 2020-04-30 | Ｉｌ－３３アンタゴニストを投与することにより喘息を治療するまたは予防するための方法 |
| JP2025080870A Pending JP2025122028A (ja) | 2019-05-01 | 2025-05-14 | Ｉｌ－３３アンタゴニストを投与することにより喘息を治療するまたは予防するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025080870A Pending JP2025122028A (ja) | 2019-05-01 | 2025-05-14 | Ｉｌ－３３アンタゴニストを投与することにより喘息を治療するまたは予防するための方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210000949A1 (enExample) |
| EP (1) | EP3962515A1 (enExample) |
| JP (2) | JP2022530533A (enExample) |
| KR (1) | KR20220004708A (enExample) |
| CN (1) | CN113766931A (enExample) |
| AU (1) | AU2020266593B2 (enExample) |
| BR (1) | BR112021021195A2 (enExample) |
| CA (1) | CA3138306A1 (enExample) |
| CO (1) | CO2021015793A2 (enExample) |
| IL (1) | IL287275A (enExample) |
| MA (1) | MA55807A (enExample) |
| MX (1) | MX2021013427A (enExample) |
| SG (1) | SG11202111255YA (enExample) |
| TW (1) | TWI894144B (enExample) |
| WO (1) | WO2020223541A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9574004B2 (en) | 2012-08-21 | 2017-02-21 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an IL-4R antagonist |
| HUE067888T2 (hu) | 2016-09-01 | 2024-11-28 | Regeneron Pharma | Módszerek az allergia megelõzésére vagy kezelésére egy IL-4R antagonista adagolásával |
| CA3132587A1 (en) | 2019-03-21 | 2020-09-24 | Regeneron Pharmaceuticals, Inc. | Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy |
| BR112022000740A2 (pt) | 2019-07-16 | 2022-07-05 | Sanofi Biotechnology | Métodos para tratamento ou prevenção de asma por administração de um antagonista de il-4r |
| KR20240049348A (ko) | 2021-08-27 | 2024-04-16 | 메디뮨 리미티드 | 항-인터루킨-33 항체를 사용한 만성 폐쇄성 폐질환의 치료 |
| CA3236201A1 (en) * | 2021-11-11 | 2023-05-19 | Regeneron Pharmaceuticals, Inc. | Treatment of lung disease based upon stratification of polygenic risk score for interleukin 33 (il-33) |
| TW202423972A (zh) | 2022-08-26 | 2024-06-16 | 英商梅迪繆思有限公司 | 使用抗介白素－３３抗體的氣喘治療 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6927044B2 (en) | 1998-09-25 | 2005-08-09 | Regeneron Pharmaceuticals, Inc. | IL-1 receptor based cytokine traps |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US8178098B2 (en) | 2001-04-03 | 2012-05-15 | National Jewish Health | Method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies |
| JP5307708B2 (ja) | 2006-06-02 | 2013-10-02 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒトｉｌ−６受容体に対する高親和性抗体 |
| NZ609557A (en) | 2010-10-06 | 2014-12-24 | Regeneron Pharma | Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies |
| US9574004B2 (en) * | 2012-08-21 | 2017-02-21 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an IL-4R antagonist |
| JO3532B1 (ar) * | 2013-03-13 | 2020-07-05 | Regeneron Pharma | الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها |
| IL315136A (en) * | 2014-02-21 | 2024-10-01 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an il-4rantagonist |
| TWI784988B (zh) * | 2016-12-01 | 2022-12-01 | 美商再生元醫藥公司 | 治療發炎症狀的方法 |
| MX2019012171A (es) * | 2017-04-13 | 2019-11-25 | Regeneron Pharma | Tratamiento e inhibicion de enfermedades pulmonares inflamatorias en pacientes que tienen alelos de riesgo en los genes que codifican la il33 e il1rl1. |
| EP3624820A1 (en) * | 2017-04-21 | 2020-03-25 | H. Hoffnabb-La Roche Ag | Use of klk5 antagonists for treatment of a disease |
-
2020
- 2020-04-30 US US16/863,800 patent/US20210000949A1/en active Pending
- 2020-04-30 MA MA055807A patent/MA55807A/fr unknown
- 2020-04-30 AU AU2020266593A patent/AU2020266593B2/en active Active
- 2020-04-30 TW TW109114586A patent/TWI894144B/zh active
- 2020-04-30 BR BR112021021195A patent/BR112021021195A2/pt unknown
- 2020-04-30 EP EP20727763.3A patent/EP3962515A1/en active Pending
- 2020-04-30 KR KR1020217038970A patent/KR20220004708A/ko active Pending
- 2020-04-30 JP JP2021564454A patent/JP2022530533A/ja active Pending
- 2020-04-30 CN CN202080032942.1A patent/CN113766931A/zh active Pending
- 2020-04-30 SG SG11202111255YA patent/SG11202111255YA/en unknown
- 2020-04-30 CA CA3138306A patent/CA3138306A1/en active Pending
- 2020-04-30 MX MX2021013427A patent/MX2021013427A/es unknown
- 2020-04-30 WO PCT/US2020/030824 patent/WO2020223541A1/en not_active Ceased
-
2021
- 2021-10-14 IL IL287275A patent/IL287275A/en unknown
- 2021-11-24 CO CONC2021/0015793A patent/CO2021015793A2/es unknown
-
2025
- 2025-05-14 JP JP2025080870A patent/JP2025122028A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022530533A5 (enExample) | ||
| JP2025038127A5 (enExample) | ||
| JP2025072593A5 (enExample) | ||
| JP2023052457A5 (enExample) | ||
| JP2023162343A5 (enExample) | ||
| EP3703818B1 (en) | Il-4r antagonist for use in a method for treating or preventing asthma | |
| JP2023052458A5 (enExample) | ||
| IL323384A (en) | Methods for treating chronic sinusitis with nasal polyps by adding an IL-4R antagonist | |
| KR102390714B1 (ko) | 벤랄리주맙을 이용하여 천식의 악화 속도를 감소시키는 방법 | |
| JP2015527364A5 (enExample) | ||
| KR102337599B1 (ko) | 벤랄리주맙을 이용하여 천식 환자에서 강제 호기량을 증가시키는 방법 | |
| JP2024129140A5 (enExample) | ||
| TWI894144B (zh) | 藉由投予il-33拮抗劑治療或預防哮喘之方法 | |
| TW201002345A (en) | Use of protease-activated receptor 2 antagonists | |
| JP2023505215A5 (enExample) | ||
| Co et al. | Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis | |
| JP2024542777A5 (enExample) | ||
| JP2020073525A5 (enExample) | ||
| RU2021134810A (ru) | Способы лечения или предупреждения астмы посредством введения антагониста il-33 | |
| Ammor et al. | 5PSQ-151 optimisation of the subcutaneous administration of daratumumab | |
| IL285483B (en) | Methods for the treatment of chronic sinusitis with nasal polyps by adding an il-4r antagonist | |
| JP2020105193A5 (enExample) | ||
| US20250388685A1 (en) | Methods for treating chronic rhinosinusitis without nasal polyps by administering an il-4r antagonist | |
| RU2023120407A (ru) | Способы лечения или предотвращения астмы посредством введения антагониста il-4r | |
| RU2556792C1 (ru) | Способ анестезии при выполнении операции циклофотокоагуляция у пациентов с синдромом "хронической" боли |